Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV ...

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement comes a month after a federal judge in New Jersey ruled that ...

On April 29, 2025, the U.S. Attorney’s Office for the Southern District of New York (SDNY) announced a $202 million civil False Claims Act ...

Gilead Sciences announced positive data regarding ... Over the three-year period ending April 2025, Gilead's total shareholder return reached 78.08%, presenting a stark contrast to more recent ...

Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks By Jonathan Stempel NEW YORK (Reuters) -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit ...

The U.S. Attorney's Office joined Bellman's lawsuit against Gilead. The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...